首页 > 最新文献

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko最新文献

英文 中文
[Focal cortical dysplasia: visual assessment of MRI and MR morphometry data]. [局灶性皮质发育不良:磁共振成像和磁共振形态测量数据的视觉评估]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro20248803145
A M Shevchenko, E L Pogosbekyan, A I Batalov, A N Tyurina, L M Fadeeva, S B Agrba, I N Pronin

Objective: Assessing the diagnostic significance of MR morphometry in determining the localization of focal cortical dysplasias (FCD).

Material and methods: The study included 13 children after surgery for drug-resistant epilepsy caused by FCD type II and stable postoperative remission of seizures (Engel class IA, median follow-up 56 months). We analyzed the results of independent expert assessment of native MR data by three radiologists (HARNESS protocol) and MR morphometry data regarding accuracy of FCD localization. We considered 2 indicators, i.e. local cortical thickening and gray-white matter blurring.

Results: FCD detection rate was higher after MR morphometry compared to visual analysis of native MR data using the HARNESS protocol. MR morphometry also makes it possible to more often identify gray-white matter blurring as a sign often missed by radiologists (p<0.05).

Conclusion: MR morphometry is an additional non-invasive method for assessing the localization of FCD.

目的:评估磁共振形态学在确定局灶性皮质发育不良(FCD)定位方面的诊断意义:评估磁共振形态学在确定局灶性皮质发育不良(FCD)定位方面的诊断意义:研究对象包括13名因FCD II型引起的耐药性癫痫而接受手术治疗且术后癫痫发作稳定缓解(恩格尔分级IA,中位随访时间56个月)的患儿。我们分析了三位放射科专家对原始 MR 数据(HARNESS 协议)和 MR 形态测量数据进行独立专家评估后得出的有关 FCD 定位准确性的结果。我们考虑了两个指标,即局部皮质增厚和灰白色物质模糊:结果:与使用 HARNESS 协议对原始 MR 数据进行视觉分析相比,MR 形态测量法的 FCD 检测率更高。磁共振形态学还能更频繁地识别灰白色物质模糊,因为这是放射科医生经常忽略的一个征象(p结论:磁共振形态测量是评估 FCD 定位的另一种非侵入性方法。
{"title":"[Focal cortical dysplasia: visual assessment of MRI and MR morphometry data].","authors":"A M Shevchenko, E L Pogosbekyan, A I Batalov, A N Tyurina, L M Fadeeva, S B Agrba, I N Pronin","doi":"10.17116/neiro20248803145","DOIUrl":"https://doi.org/10.17116/neiro20248803145","url":null,"abstract":"<p><strong>Objective: </strong>Assessing the diagnostic significance of MR morphometry in determining the localization of focal cortical dysplasias (FCD).</p><p><strong>Material and methods: </strong>The study included 13 children after surgery for drug-resistant epilepsy caused by FCD type II and stable postoperative remission of seizures (Engel class IA, median follow-up 56 months). We analyzed the results of independent expert assessment of native MR data by three radiologists (HARNESS protocol) and MR morphometry data regarding accuracy of FCD localization. We considered 2 indicators, i.e. local cortical thickening and gray-white matter blurring.</p><p><strong>Results: </strong>FCD detection rate was higher after MR morphometry compared to visual analysis of native MR data using the HARNESS protocol. MR morphometry also makes it possible to more often identify gray-white matter blurring as a sign often missed by radiologists (<i>p</i><0.05).</p><p><strong>Conclusion: </strong>MR morphometry is an additional non-invasive method for assessing the localization of FCD.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141331879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparative analysis of combined treatment methods for patients with single brain lesions]. [单一脑损伤患者的综合治疗方法比较分析]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro20248804113
M Yu Ostapenko, V A Lukshin, D Yu Usachev, A V Golanov, E R Vetlova, A A Durgaryan, N G Kobyakov

Primary brain metastases are common in oncology. Preoperative stereotactic radiosurgery followed by surgical resection is a perspective approach.

Objective: To evaluate own experience of preoperative radiosurgery followed by surgical resection (RS+S) of metastasis regarding local control, leptomeningeal progression, surgical and radiation-induced complications; to compare treatment outcomes with surgical resection and subsequent radiotherapy (S+SRT).

Material and methods. a: Retrospective study included 66 patients with solitary brain metastasis. Two groups of patients were distinguished: group 1 (n=34) - postoperative irradiation, group 2 (n=32) - preoperative irradiation. The median age was 49.5 years (range 36-75).

Results: Local 3-, 6- and 12-month control among patients with postoperative irradiation was 88.2%, 79.4% and 42.9%, in the group of preoperative irradiation - 100%, 93.3% and 66.7%, respectively (p=0.021). Leptomeningeal progression developed in 11 patients (8 and 3 ones, respectively). The one-year survival rate was 73.5% and 84.4%, respectively (p=0.33). Long-term surgical and radiation-induced complications occurred in 12 (18.2%) patients.

Conclusion: Preoperative radiosurgery with subsequent resection provides higher local control and lower incidence of leptomeningeal progression in patients with single brain metastases.

原发性脑转移瘤在肿瘤学中很常见。术前立体定向放射外科手术后再进行手术切除是一种前景广阔的方法:评估术前放射外科手术后手术切除(RS+S)转移瘤的局部控制、脑白质进展、手术和放射引起的并发症等方面的经验;比较手术切除后放疗(S+SRT)的治疗效果。分为两组:第一组(34人)--术后照射,第二组(32人)--术前照射。中位年龄为 49.5 岁(36-75 岁不等):结果:术后照射患者3个月、6个月和12个月的局部控制率分别为88.2%、79.4%和42.9%,术前照射组分别为100%、93.3%和66.7%(P=0.021)。11例患者(分别为8例和3例)出现了脑膜病变。一年生存率分别为73.5%和84.4%(P=0.33)。12名患者(18.2%)出现了手术和放射引起的长期并发症:结论:对单发脑转移瘤患者来说,术前放射外科手术和随后的切除术可提供更高的局部控制率,并降低脑转移瘤进展的发生率。
{"title":"[Comparative analysis of combined treatment methods for patients with single brain lesions].","authors":"M Yu Ostapenko, V A Lukshin, D Yu Usachev, A V Golanov, E R Vetlova, A A Durgaryan, N G Kobyakov","doi":"10.17116/neiro20248804113","DOIUrl":"https://doi.org/10.17116/neiro20248804113","url":null,"abstract":"<p><p>Primary brain metastases are common in oncology. Preoperative stereotactic radiosurgery followed by surgical resection is a perspective approach.</p><p><strong>Objective: </strong>To evaluate own experience of preoperative radiosurgery followed by surgical resection (RS+S) of metastasis regarding local control, leptomeningeal progression, surgical and radiation-induced complications; to compare treatment outcomes with surgical resection and subsequent radiotherapy (S+SRT).</p><p><strong>Material and methods. a: </strong>Retrospective study included 66 patients with solitary brain metastasis. Two groups of patients were distinguished: group 1 (<i>n</i>=34) - postoperative irradiation, group 2 (<i>n</i>=32) - preoperative irradiation. The median age was 49.5 years (range 36-75).</p><p><strong>Results: </strong>Local 3-, 6- and 12-month control among patients with postoperative irradiation was 88.2%, 79.4% and 42.9%, in the group of preoperative irradiation - 100%, 93.3% and 66.7%, respectively (<i>p</i>=0.021). Leptomeningeal progression developed in 11 patients (8 and 3 ones, respectively). The one-year survival rate was 73.5% and 84.4%, respectively (<i>p</i>=0.33). Long-term surgical and radiation-induced complications occurred in 12 (18.2%) patients.</p><p><strong>Conclusion: </strong>Preoperative radiosurgery with subsequent resection provides higher local control and lower incidence of leptomeningeal progression in patients with single brain metastases.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142018875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Endoscopic transnasal resection of clival meningiomas]. [内镜下经鼻腔切除簇状脑膜瘤]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro202488021105
A N Shkarubo, I V Chernov, A A Veselkov, D N Andreev, Z F Yakupova, P P Kalinin

Background: Surgical treatment of ventral and ventrolateral meningiomas of posterior cranial fossa is difficult in modern neurosurgery. This is due to peculiarities of approach to these areas and concentration of critical structures (cranial nerves and great vessels). Currently, endoscopic transnasal approach to these meningiomas allows partial, and in some cases, total resection. However, this technique is not widespread.

Objective: To analyze the world literature data on postoperative outcomes in patients with clival and petroclival meningiomas after endoscopic transnasal resection.

Material and methods: We analyzed 22 articles representing treatment of 61 patients with clival and petroclival meningiomas.

Results: Total or near-total resection was achieved in 22.9% of cases, subtotal resection - 40.9%, partial resection - 26.2% (data were not provided in other cases). Even partial and subtotal resection leads to significant regression of symptoms.

Conclusion: Endoscopic transnasal surgery is a full-fledged alternative to transcranial approaches in surgical treatment of clival meningiomas. It is also an additional option for patients with petroclival meningiomas after ineffective transcranial approaches. Transnasal tumor shrinkage and devascularization lead to brainstem decompression, regression of hydrocephalus and baseline clinical symptoms.

背景:在现代神经外科中,后颅窝腹侧和腹外侧脑膜瘤的手术治疗非常困难。这是因为进入这些区域的方法有其特殊性,而且关键结构(颅神经和大血管)集中在这些区域。目前,通过内窥镜经鼻方法可以对这些脑膜瘤进行部分切除,在某些情况下甚至可以进行全部切除。然而,这种技术尚未普及:材料和方法:我们分析了22篇文章,共治疗了62例脑膜瘤患者:我们分析了22篇文章,这些文章代表了对61名壁间和瓣间脑膜瘤患者的治疗结果:结果:22.9%的病例实现了全切除或接近全切除,40.9%的病例实现了次全切除,26.2%的病例实现了部分切除(其他病例未提供数据)。结论:即使是部分和次全切除术也能使症状明显缓解:结论:内窥镜经鼻手术是经颅手术治疗蝶鞍脑膜瘤的全面替代方案。结论:经鼻内窥镜手术完全可以替代经颅入路手术治疗蝶鞍状脑膜瘤,也是经颅入路无效的瓣膜状脑膜瘤患者的另一种选择。经鼻肿瘤缩小和血管离断可导致脑干减压、脑积水消退和基本临床症状。
{"title":"[Endoscopic transnasal resection of clival meningiomas].","authors":"A N Shkarubo, I V Chernov, A A Veselkov, D N Andreev, Z F Yakupova, P P Kalinin","doi":"10.17116/neiro202488021105","DOIUrl":"10.17116/neiro202488021105","url":null,"abstract":"<p><strong>Background: </strong>Surgical treatment of ventral and ventrolateral meningiomas of posterior cranial fossa is difficult in modern neurosurgery. This is due to peculiarities of approach to these areas and concentration of critical structures (cranial nerves and great vessels). Currently, endoscopic transnasal approach to these meningiomas allows partial, and in some cases, total resection. However, this technique is not widespread.</p><p><strong>Objective: </strong>To analyze the world literature data on postoperative outcomes in patients with clival and petroclival meningiomas after endoscopic transnasal resection.</p><p><strong>Material and methods: </strong>We analyzed 22 articles representing treatment of 61 patients with clival and petroclival meningiomas.</p><p><strong>Results: </strong>Total or near-total resection was achieved in 22.9% of cases, subtotal resection - 40.9%, partial resection - 26.2% (data were not provided in other cases). Even partial and subtotal resection leads to significant regression of symptoms.</p><p><strong>Conclusion: </strong>Endoscopic transnasal surgery is a full-fledged alternative to transcranial approaches in surgical treatment of clival meningiomas. It is also an additional option for patients with petroclival meningiomas after ineffective transcranial approaches. Transnasal tumor shrinkage and devascularization lead to brainstem decompression, regression of hydrocephalus and baseline clinical symptoms.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140319364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Genetic factors in degenerative disc disease]. [椎间盘退行性病变的遗传因素]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro202488021112
V A Chekhonatsky, K B Mirzaev, G V Pavlova, D Yu Usachev, N B Zakharova, A A Chekhonatsky, A V Kuznetsov, A V Gorozhanin, O N Dreval

Objective: To analyze available literature data on the role of genetic factors in degenerative disc disease.

Methodology: We reviewed the PubMed, MEDLINE, Cohrane Library, e-Library databases using the following keywords: degenerative spine lesions, intervertebral disc herniation, pathogenesis, genetic regulation.

Results: Searching depth was 2002-2022. We reviewed 84 references. Exclusion criteria: duplicate publications, reviews without detailed description of results, opinions. Finally, we included 43 the most significant studies.

Conclusion: There are literature data on proinflammatory cytokines, growth factors and osteodestructive processes in pathogenesis of degenerative disc disease. However, there is only fragmentary information about the role of genetic regulation of these processes. Some factors, such as microRNA, TGF-b, VEGF, MMP are still poorly understood.

目的分析有关遗传因素在椎间盘退行性病变中作用的现有文献数据:我们使用以下关键词查阅了 PubMed、MEDLINE、Cohrane Library 和 e-Library 数据库:脊柱退行性病变、椎间盘突出症、发病机制、遗传调节:检索深度为 2002-2022 年。我们查阅了 84 篇参考文献。排除标准:重复发表、未详细描述结果的综述、观点。最后,我们纳入了 43 项最重要的研究:关于椎间盘退行性病变发病机制中的促炎细胞因子、生长因子和骨破坏过程的文献资料很多。然而,关于这些过程的遗传调控作用的信息却很零散。一些因子,如 microRNA、TGF-b、VEGF、MMP 等,目前仍不甚明了。
{"title":"[Genetic factors in degenerative disc disease].","authors":"V A Chekhonatsky, K B Mirzaev, G V Pavlova, D Yu Usachev, N B Zakharova, A A Chekhonatsky, A V Kuznetsov, A V Gorozhanin, O N Dreval","doi":"10.17116/neiro202488021112","DOIUrl":"10.17116/neiro202488021112","url":null,"abstract":"<p><strong>Objective: </strong>To analyze available literature data on the role of genetic factors in degenerative disc disease.</p><p><strong>Methodology: </strong>We reviewed the PubMed, MEDLINE, Cohrane Library, e-Library databases using the following keywords: degenerative spine lesions, intervertebral disc herniation, pathogenesis, genetic regulation.</p><p><strong>Results: </strong>Searching depth was 2002-2022. We reviewed 84 references. Exclusion criteria: duplicate publications, reviews without detailed description of results, opinions. Finally, we included 43 the most significant studies.</p><p><strong>Conclusion: </strong>There are literature data on proinflammatory cytokines, growth factors and osteodestructive processes in pathogenesis of degenerative disc disease. However, there is only fragmentary information about the role of genetic regulation of these processes. Some factors, such as microRNA, TGF-b, VEGF, MMP are still poorly understood.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140319365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Covalently conjugated DNA aptamer with doxorubicin as in vitro model for effective targeted drug delivery to human glioblastoma tumor cells]. [将与多柔比星共价共轭的 DNA aptamer 作为体外模型,对人类胶质母细胞瘤肿瘤细胞进行有效的靶向给药]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro20248801148
Ya A Sliman, N S Samoylenkova, O M Antipova, V A Brylev, D A Veryutin, K A Sapozhnikova, A I Alekseeva, I N Pronin, A M Kopylov, G V Pavlova

Targeted delivery of chemotherapeutic agents with aptamers is a very effective method increasing therapeutic index compared to non-targeted drugs.

Objective: To study the effectiveness of in vitro therapeutic effect of covalently conjugated GR20 DNA aptamer with doxorubicin on glioblastoma cells compared to reference culture of human fibroblasts.

Material and methods: A Sus/fP2 cell culture was obtained from glioblastoma tissue sample to analyze the effectiveness of conjugate. A linear culture of human dermal fibroblasts (mesenchymal stem cells) DF1 was used as a control. To assess antiproliferative activity of covalently conjugated GR20 aptamer with doxorubicin, we used the MTS test. The Cell Index was measured using the xCelligence S16 cell analyzer assessing viability of cell cultures by recording changes in real time.

Results: Human glioblastoma Sus/fP2 cells reduce own proliferative potential by 80% when exposed to doxorubicin (0.5 µM, 72 hours, MTS test), by 9% when exposed to GR20 aptamer (10 µM, 72 hours, MTS test) and by 26% when exposed to covalently conjugated DOX-GR20 (0.5 µM, 72 hours, MTS test). A long-term study of proliferative potential of Sus/fP2 cells on the xCelligence S16 analyzer revealed a significant decrease in the number of cells under the effect of doxorubicin and covalently conjugated DOX-GR20. Effectiveness of covalently conjugated DOX-GR20 is halved. GR20 aptamer at a concentration of 10 μM and its conjugate with doxorubicin DOX-GR20 at a concentration of 1 μM have no negative effect on cells of the control culture of DF1 fibroblasts, while doxorubicin is toxic for these cells. MTS test and xCelligence S16 cell analyzer found no decrease in metabolic activity of DF1 cells and their ability to proliferate.

Conclusion: We established obvious antiproliferative effect of covalent conjugate DOX-GR20 on continuous human glioblastoma cell culture Sus/fP2 without toxic effect on the reference culture (dermal fibroblasts DF1).

与非靶向药物相比,用适配体靶向递送化疗药物是提高治疗指数的一种非常有效的方法:与参考培养的人成纤维细胞相比,研究与多柔比星共价共轭的GR20 DNA适配体对胶质母细胞瘤细胞的体外治疗效果:从胶质母细胞瘤组织样本中获得Sus/fP2细胞培养物,以分析共轭物的有效性。人真皮成纤维细胞(间充质干细胞)DF1 的线性培养物用作对照。为了评估与多柔比星共价共轭的 GR20 aptamer 的抗增殖活性,我们使用了 MTS 测试。使用 xCelligence S16 细胞分析仪测量细胞指数,通过实时记录变化来评估细胞培养物的活力:结果:人胶质母细胞瘤 Sus/fP2 细胞暴露于多柔比星(0.5 µM,72 小时,MTS 测试)时,自身增殖潜能降低了 80%;暴露于 GR20 aptamer(10 µM,72 小时,MTS 测试)时,自身增殖潜能降低了 9%;暴露于共价结合的 DOX-GR20 (0.5 µM,72 小时,MTS 测试)时,自身增殖潜能降低了 26%。在 xCelligence S16 分析仪上对 Sus/fP2 细胞增殖潜力的长期研究显示,在多柔比星和共价结合 DOX-GR20 的作用下,细胞数量显著减少。共价结合 DOX-GR20 的效果减半。浓度为 10 μM 的 GR20 aptamer 及其与多柔比星的共轭物 DOX-GR20 (浓度为 1 μM)对 DF1 成纤维细胞对照培养物的细胞没有负面影响,而多柔比星对这些细胞具有毒性。MTS 测试和 xCelligence S16 细胞分析仪发现 DF1 细胞的代谢活性和增殖能力没有下降:我们证实了共价共轭物 DOX-GR20 对连续培养的人胶质母细胞瘤细胞 Sus/fP2 有明显的抗增殖作用,而对参考培养物(皮肤成纤维细胞 DF1)无毒性影响。
{"title":"[Covalently conjugated DNA aptamer with doxorubicin as in vitro model for effective targeted drug delivery to human glioblastoma tumor cells].","authors":"Ya A Sliman, N S Samoylenkova, O M Antipova, V A Brylev, D A Veryutin, K A Sapozhnikova, A I Alekseeva, I N Pronin, A M Kopylov, G V Pavlova","doi":"10.17116/neiro20248801148","DOIUrl":"10.17116/neiro20248801148","url":null,"abstract":"<p><p>Targeted delivery of chemotherapeutic agents with aptamers is a very effective method increasing therapeutic index compared to non-targeted drugs.</p><p><strong>Objective: </strong>To study the effectiveness of in vitro therapeutic effect of covalently conjugated GR20 DNA aptamer with doxorubicin on glioblastoma cells compared to reference culture of human fibroblasts.</p><p><strong>Material and methods: </strong>A Sus/fP2 cell culture was obtained from glioblastoma tissue sample to analyze the effectiveness of conjugate. A linear culture of human dermal fibroblasts (mesenchymal stem cells) DF1 was used as a control. To assess antiproliferative activity of covalently conjugated GR20 aptamer with doxorubicin, we used the MTS test. The Cell Index was measured using the xCelligence S16 cell analyzer assessing viability of cell cultures by recording changes in real time.</p><p><strong>Results: </strong>Human glioblastoma Sus/fP2 cells reduce own proliferative potential by 80% when exposed to doxorubicin (0.5 µM, 72 hours, MTS test), by 9% when exposed to GR20 aptamer (10 µM, 72 hours, MTS test) and by 26% when exposed to covalently conjugated DOX-GR20 (0.5 µM, 72 hours, MTS test). A long-term study of proliferative potential of Sus/fP2 cells on the xCelligence S16 analyzer revealed a significant decrease in the number of cells under the effect of doxorubicin and covalently conjugated DOX-GR20. Effectiveness of covalently conjugated DOX-GR20 is halved. GR20 aptamer at a concentration of 10 μM and its conjugate with doxorubicin DOX-GR20 at a concentration of 1 μM have no negative effect on cells of the control culture of DF1 fibroblasts, while doxorubicin is toxic for these cells. MTS test and xCelligence S16 cell analyzer found no decrease in metabolic activity of DF1 cells and their ability to proliferate.</p><p><strong>Conclusion: </strong>We established obvious antiproliferative effect of covalent conjugate DOX-GR20 on continuous human glioblastoma cell culture Sus/fP2 without toxic effect on the reference culture (dermal fibroblasts DF1).</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139708067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[National and world experience in functioning of centers for collective use of biological resource collections of tumors of the central nervous system]. [集体使用中枢神经系统肿瘤生物资源收藏中心的国家和世界运作经验]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro20248803159
A V Kosyrkova, D V Gusev, S A Goryainov, A D Kravchuk, A A Aristov, A I Batalov, N E Zakharova, S V Shugai, G V Pavlova, I N Pronin

Collective use center is an organization or structural unit with unique resource providing access to this resource for internal and third-party users. Collective use centers are a relatively new phenomenon in bioresource collections, especially collections of human biological material due to some ethical and legal issues. At the same time, the demand for human biological material continues to grow in fundamental and applied researches. The collective use center «Bioresource collection of tissues and cell cultures of tumors of the human nervous system for fundamental and applied researches» has worked since October 14, 2022. This center has access to unique collection of the Laboratory of Neurosurgical Anatomy and Conservation of Human Biological Tissues of the Burdenko Neurosurgical Center.

Objective: To analyze the experience of collective use center and biobank of the Burdenko Neurosurgical Center compared to national and international data on functioning of collective use centers specializing in tumors of the human central nervous system.

Material and methods: We reviewed the PubMed and e-Library databases using the following keywords: core facilities brain tumors, repository of collective use brain tumors, biobank of CNS tumors, central nervous system tumor collection centers. We also analyzed the organizations registered on the portal of scientific and technical infrastructure of the Russian Federation.

Results: We analyzed 275 publications devoted to collective use centers and biobanks. These biobanks do not position themselves as collective use centers but actively realize biological material for researches. Structure of institutions presented on the portal of scientific and technical infrastructure of the Russian Federation is characterized. The collective use center «Bioresource collection of tissues and cell cultures of tumors of the human nervous system for fundamental and applied researches» has access to biobank of the Burdenko Neurosurgical Center. To date, the biobank contains more than 8478 aliquots of tumor tissue frozen at ultra-low temperature (-196°C) and obtained from 1993 patients. Considering available data, we established the basic principles of work in collective use centers with bioresource collections.

Conclusion: Collective use centers with bioresource collections of tumors of the central nervous system are rare. There is only one collective use center organized at the Burdenko Neurosurgical Center on the portal of scientific and technical infrastructure of the Russian Federation. At the same time, there is an urgent need to increase their number and activity in Russia and other countries worldwide. You can use the resource of brain tumor collections by leaving a request on the official website of this organization in the «Collective use center» section.

集体使用中心是一个拥有独特资源的组织或结构单元,为内部和第三方用户提供使用该资源的机会。由于一些伦理和法律问题,在生物资源收藏,特别是人类生物材料收藏方面,集体使用中心是一个相对较新的现象。与此同时,基础研究和应用研究对人类生物材料的需求持续增长。自 2022 年 10 月 14 日起,"用于基础研究和应用研究的人类神经系统肿瘤组织和细胞培养物生物资源收藏 "集体使用中心开始工作。该中心可以使用布尔登科神经外科中心神经外科解剖和人类生物组织保存实验室的独特藏品:分析布尔登科神经外科中心集体使用中心和生物库的经验,并与国内和国际上专门从事人类中枢神经系统肿瘤研究的集体使用中心的运作数据进行比较:我们使用以下关键词查阅了 PubMed 和电子图书馆数据库:脑肿瘤核心设施、脑肿瘤集体使用存储库、中枢神经系统肿瘤生物库、中枢神经系统肿瘤收集中心。我们还分析了在俄罗斯联邦科技基础设施门户网站上注册的组织:我们分析了 275 篇有关集体使用中心和生物库的出版物。这些生物库并没有将自己定位为集体使用中心,而是积极地将生物材料用于研究。在俄罗斯联邦科技基础设施门户网站上介绍了这些机构的结构特点。集体使用中心 "用于基础研究和应用研究的人体神经系统肿瘤组织和细胞培养物的生物资源收集 "可以使用布尔登科神经外科中心的生物库。迄今为止,该生物库包含超过 8478 份在超低温(-196°C)下冷冻的肿瘤组织等分试样,这些试样来自 1993 名患者。根据现有数据,我们制定了生物资源集体使用中心的基本工作原则:结论:中枢神经系统肿瘤生物资源集体使用中心非常罕见。在俄罗斯联邦科技基础设施门户网站上,只有布尔登科神经外科中心一家集体使用中心。同时,在俄罗斯和世界其他国家迫切需要增加这些中心的数量和活动。您可以在该组织的官方网站上的 "集体使用中心 "栏目中提出申请,以使用脑肿瘤收集资源。
{"title":"[National and world experience in functioning of centers for collective use of biological resource collections of tumors of the central nervous system].","authors":"A V Kosyrkova, D V Gusev, S A Goryainov, A D Kravchuk, A A Aristov, A I Batalov, N E Zakharova, S V Shugai, G V Pavlova, I N Pronin","doi":"10.17116/neiro20248803159","DOIUrl":"https://doi.org/10.17116/neiro20248803159","url":null,"abstract":"<p><p>Collective use center is an organization or structural unit with unique resource providing access to this resource for internal and third-party users. Collective use centers are a relatively new phenomenon in bioresource collections, especially collections of human biological material due to some ethical and legal issues. At the same time, the demand for human biological material continues to grow in fundamental and applied researches. The collective use center «Bioresource collection of tissues and cell cultures of tumors of the human nervous system for fundamental and applied researches» has worked since October 14, 2022. This center has access to unique collection of the Laboratory of Neurosurgical Anatomy and Conservation of Human Biological Tissues of the Burdenko Neurosurgical Center.</p><p><strong>Objective: </strong>To analyze the experience of collective use center and biobank of the Burdenko Neurosurgical Center compared to national and international data on functioning of collective use centers specializing in tumors of the human central nervous system.</p><p><strong>Material and methods: </strong>We reviewed the PubMed and e-Library databases using the following keywords: core facilities brain tumors, repository of collective use brain tumors, biobank of CNS tumors, central nervous system tumor collection centers. We also analyzed the organizations registered on the portal of scientific and technical infrastructure of the Russian Federation.</p><p><strong>Results: </strong>We analyzed 275 publications devoted to collective use centers and biobanks. These biobanks do not position themselves as collective use centers but actively realize biological material for researches. Structure of institutions presented on the portal of scientific and technical infrastructure of the Russian Federation is characterized. The collective use center «Bioresource collection of tissues and cell cultures of tumors of the human nervous system for fundamental and applied researches» has access to biobank of the Burdenko Neurosurgical Center. To date, the biobank contains more than 8478 aliquots of tumor tissue frozen at ultra-low temperature (-196°C) and obtained from 1993 patients. Considering available data, we established the basic principles of work in collective use centers with bioresource collections.</p><p><strong>Conclusion: </strong>Collective use centers with bioresource collections of tumors of the central nervous system are rare. There is only one collective use center organized at the Burdenko Neurosurgical Center on the portal of scientific and technical infrastructure of the Russian Federation. At the same time, there is an urgent need to increase their number and activity in Russia and other countries worldwide. You can use the resource of brain tumor collections by leaving a request on the official website of this organization in the «Collective use center» section.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141331883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Venous cerebral complications after microsurgery for complex aneurysms of the middle cerebral arteries]. [大脑中动脉复杂动脉瘤显微手术后的脑静脉并发症]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro20248803114
Yu V Pilipenko, Sh Sh Eliava, O B Belousova, D N Okishev, An N Konovalov, A V Tsarikaev

Microsurgeries are common for complex aneurysms of the middle cerebral artery (MCA).

Objective: To evaluate the incidence and types of venous cerebral disorders after microsurgeries for complex MCA aneurysms.

Material and methods: A retrospective study included 285 patients with complex MCA aneurysms between 2009 and 2020. Pterional craniotomy and transsylvian approach were used in all cases. Aneurysm clipping was performed in 230 cases, revascularization - 27, trapping without bypass - 17, reinforcement - in 11 cases. Computed tomography within 1-3 days after surgery recognized venous cerebral disorders as heterogeneous foci of abnormal brain density with unclear boundaries. These foci were crescent-shaped as a rule and located in deep and basal parts of the frontal lobes.

Results: Venous abnormalities occurred in 76 (26.7%) patients. Thirty-five (12.3%) patients had mild venous edema of the frontal lobe alone. In 35 (12.3%) patients, we found moderate disorders with focus in the frontal lobe and compression of anterior horn of the left lateral ventricle with or without hemorrhagic imbibition. Severe disorders occurred in 6 (2.1%) patients with lesion extending to the frontal, insular and temporal lobes. These lesions were accompanied by hemorrhagic imbibition, and lateral dislocation exceeded 5 mm.

Conclusion: Careful dissection of veins in Sylvian fissure with preservation of bridging veins is likely to reduce the risk of this complication. Cauterization of a large vein in Sylvian fissure should be followed by careful hemostasis within frontal or temporal cortex. Bleeding and cortical tension can indicate intracerebral hematoma whose likelihood is higher in patients with venous cerebral disorders.

大脑中动脉(MCA)复杂动脉瘤显微手术很常见:评估复杂MCA动脉瘤显微手术后脑静脉疾病的发生率和类型:一项回顾性研究纳入了2009年至2020年间的285例复杂MCA动脉瘤患者。所有病例均采用了翼状开颅术和经侧韧带入路术。230例进行了动脉瘤夹闭,27例进行了血管重建,17例进行了无旁路夹闭,11例进行了动脉瘤加固。术后1-3天内进行的计算机断层扫描发现,脑静脉疾病表现为边界不清的异质脑密度异常灶。这些病灶通常呈新月形,位于额叶的深部和基底部分:76例(26.7%)患者出现静脉异常。35例(12.3%)患者仅额叶有轻度静脉水肿。在 35 名(12.3%)患者中,我们发现了中度病变,病灶位于额叶,左侧外侧脑室前角受压,伴有或不伴有出血浸润。重度患者有 6 例(2.1%),病变扩展到额叶、岛叶和颞叶。这些病变伴有出血浸润,侧位超过 5 毫米:结论:仔细解剖Sylvian裂隙中的静脉并保留桥接静脉可能会降低这种并发症的风险。在灼烧 Sylvian 裂隙中的大静脉后,应在额叶或颞叶皮质内仔细止血。出血和皮质张力可能预示着脑内血肿,脑静脉疾病患者出现脑内血肿的可能性更高。
{"title":"[Venous cerebral complications after microsurgery for complex aneurysms of the middle cerebral arteries].","authors":"Yu V Pilipenko, Sh Sh Eliava, O B Belousova, D N Okishev, An N Konovalov, A V Tsarikaev","doi":"10.17116/neiro20248803114","DOIUrl":"https://doi.org/10.17116/neiro20248803114","url":null,"abstract":"<p><p>Microsurgeries are common for complex aneurysms of the middle cerebral artery (MCA).</p><p><strong>Objective: </strong>To evaluate the incidence and types of venous cerebral disorders after microsurgeries for complex MCA aneurysms.</p><p><strong>Material and methods: </strong>A retrospective study included 285 patients with complex MCA aneurysms between 2009 and 2020. Pterional craniotomy and transsylvian approach were used in all cases. Aneurysm clipping was performed in 230 cases, revascularization - 27, trapping without bypass - 17, reinforcement - in 11 cases. Computed tomography within 1-3 days after surgery recognized venous cerebral disorders as heterogeneous foci of abnormal brain density with unclear boundaries. These foci were crescent-shaped as a rule and located in deep and basal parts of the frontal lobes.</p><p><strong>Results: </strong>Venous abnormalities occurred in 76 (26.7%) patients. Thirty-five (12.3%) patients had mild venous edema of the frontal lobe alone. In 35 (12.3%) patients, we found moderate disorders with focus in the frontal lobe and compression of anterior horn of the left lateral ventricle with or without hemorrhagic imbibition. Severe disorders occurred in 6 (2.1%) patients with lesion extending to the frontal, insular and temporal lobes. These lesions were accompanied by hemorrhagic imbibition, and lateral dislocation exceeded 5 mm.</p><p><strong>Conclusion: </strong>Careful dissection of veins in Sylvian fissure with preservation of bridging veins is likely to reduce the risk of this complication. Cauterization of a large vein in Sylvian fissure should be followed by careful hemostasis within frontal or temporal cortex. Bleeding and cortical tension can indicate intracerebral hematoma whose likelihood is higher in patients with venous cerebral disorders.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141331889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Posterior petrous meningioma with secondary trigeminal neuralgia: microsurgical resection after stereotactic radiosurgery (case report and literature review)]. [后花盆脑膜瘤伴继发性三叉神经痛:立体定向放射外科手术后的显微外科切除术(病例报告和文献综述)]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro20248804185
K S Gordienko, A V Trashin, V V Stepanenko, Yu A Shulev

According to the literature, cerebellopontine angle tumors cause secondary trigeminal neuralgia and other symptoms of neurovascular compression in 1-9.9% of cases. We present a 58-year-old patient with left-sided secondary trigeminal neuralgia caused by ipsilateral posterior petrous meningioma. Stereotactic irradiation was followed by effective tumor growth control. However, residual trigeminal pain paroxysms significantly reduced the quality of life and required subsequent microsurgery. Trigeminal facial pain regressed after total resection of tumor. Considering this clinical case, we would like to discuss several issues: follow-up of meningioma requiring radiosurgery, course of secondary trigeminal neuralgia in a patient with apical petrous meningioma, characteristics of pain before and after radiosurgery, the best treatment option for these patients. Stereotactic radiosurgery seems unreasonable for CPA tumors with secondary trigeminal neuralgia. Indeed, persistent pain is possible even after tumor shrinkage. Moreover, primary stereotactic irradiation significantly complicates subsequent resection of tumor.

根据文献报道,小脑角肿瘤引起继发性三叉神经痛和其他神经血管压迫症状的病例占 1-9.9% 。我们接诊了一位58岁的患者,她患有同侧后枕部脑膜瘤引起的左侧继发性三叉神经痛。立体定向照射后,肿瘤生长得到有效控制。然而,残留的三叉神经痛阵发性发作大大降低了患者的生活质量,因此需要进行显微手术。肿瘤完全切除后,三叉神经面部疼痛缓解。考虑到这一临床病例,我们想就以下几个问题展开讨论:需要进行放射外科手术的脑膜瘤的随访、顶枕部脑膜瘤患者继发性三叉神经痛的病程、放射外科手术前后疼痛的特点、这些患者的最佳治疗方案。对于伴有继发性三叉神经痛的 CPA 肿瘤,立体定向放射外科手术似乎并不合理。事实上,即使肿瘤缩小,也可能出现持续性疼痛。此外,原发性立体定向照射会使随后的肿瘤切除术变得更加复杂。
{"title":"[Posterior petrous meningioma with secondary trigeminal neuralgia: microsurgical resection after stereotactic radiosurgery (case report and literature review)].","authors":"K S Gordienko, A V Trashin, V V Stepanenko, Yu A Shulev","doi":"10.17116/neiro20248804185","DOIUrl":"https://doi.org/10.17116/neiro20248804185","url":null,"abstract":"<p><p>According to the literature, cerebellopontine angle tumors cause secondary trigeminal neuralgia and other symptoms of neurovascular compression in 1-9.9% of cases. We present a 58-year-old patient with left-sided secondary trigeminal neuralgia caused by ipsilateral posterior petrous meningioma. Stereotactic irradiation was followed by effective tumor growth control. However, residual trigeminal pain paroxysms significantly reduced the quality of life and required subsequent microsurgery. Trigeminal facial pain regressed after total resection of tumor. Considering this clinical case, we would like to discuss several issues: follow-up of meningioma requiring radiosurgery, course of secondary trigeminal neuralgia in a patient with apical petrous meningioma, characteristics of pain before and after radiosurgery, the best treatment option for these patients. Stereotactic radiosurgery seems unreasonable for CPA tumors with secondary trigeminal neuralgia. Indeed, persistent pain is possible even after tumor shrinkage. Moreover, primary stereotactic irradiation significantly complicates subsequent resection of tumor.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142018882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Optic canal stenosis in Crouzon syndrome: a case report and literature review]. [克鲁宗综合征视神经管狭窄:病例报告和文献综述]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro202488041100
I V Bolotnikova, A S Shapovalov, T B Bazarkhandaeva, V P Ivanov, V A Khachatryan, D A Gulyaev, V V Brzhesky, A V Kim

Background: Incidence of Crouzon syndrome is 1 per 25.000-31.000 newborns. This syndrome is extremely rarely accompanied by optic canal stenosis.

Objective: To present a patient with Crouzon syndrome and optic canal stenosis, to discuss the management of such patients considering own and literature data.

Material and methods: A 6-year-old boy presented with Crouzon syndrome (verified by molecular genetic research, i.e. FGFR2 gene mutation). The patient underwent 3 surgeries for craniosynostosis and hydrocephalus. Nevertheless, visual acuity progressively decreased despite patent ventriculoperitoneal shunt. Examination revealed severe decrease in visual functions with optic disc congestion under secondary atrophy. MRI data on subarachnoid CSF accumulation over both optic nerves potentially indicated optic canal stenosis. This assumption was confirmed by 3D CT.

Results: The patient underwent decompression of both optic canals with subsequent improvement of visual functions.

Conclusion: Vision decrease following Crouzon syndrome may be due to optic canal stenosis. Decompression may be effective, even in long-term course of disease, and improve visual functions.

背景:克鲁宗综合征的发病率为每 2.5 万至 3.1 万名新生儿中 1 例。该综合征极少伴有视神经管狭窄:介绍一名患有克鲁宗综合征和视神经管狭窄的患者,并根据患者自身情况和文献资料讨论此类患者的治疗方法:一名 6 岁男孩患有克鲁宗综合征(经分子遗传学研究证实,即 FGFR2 基因突变)。患者曾因颅骨发育不良和脑积水接受过 3 次手术。尽管如此,尽管脑室腹腔分流管通畅,患者的视力仍逐渐下降。检查发现,患者视功能严重下降,视盘充血,继发性萎缩。核磁共振成像数据显示,蛛网膜下腔CSF积聚在双侧视神经上,这可能表明视神经管狭窄。三维 CT 证实了这一推测:结果:患者接受了双侧视神经管减压术,随后视功能得到改善:结论:克鲁宗综合征后视力下降可能是视神经管狭窄所致。结论:克鲁宗综合征后视力下降可能是由于视神经管狭窄所致,减压术即使在长期病程中也可能有效,并能改善视功能。
{"title":"[Optic canal stenosis in Crouzon syndrome: a case report and literature review].","authors":"I V Bolotnikova, A S Shapovalov, T B Bazarkhandaeva, V P Ivanov, V A Khachatryan, D A Gulyaev, V V Brzhesky, A V Kim","doi":"10.17116/neiro202488041100","DOIUrl":"https://doi.org/10.17116/neiro202488041100","url":null,"abstract":"<p><strong>Background: </strong>Incidence of Crouzon syndrome is 1 per 25.000-31.000 newborns. This syndrome is extremely rarely accompanied by optic canal stenosis.</p><p><strong>Objective: </strong>To present a patient with Crouzon syndrome and optic canal stenosis, to discuss the management of such patients considering own and literature data.</p><p><strong>Material and methods: </strong>A 6-year-old boy presented with Crouzon syndrome (verified by molecular genetic research, i.e. FGFR2 gene mutation). The patient underwent 3 surgeries for craniosynostosis and hydrocephalus. Nevertheless, visual acuity progressively decreased despite patent ventriculoperitoneal shunt. Examination revealed severe decrease in visual functions with optic disc congestion under secondary atrophy. MRI data on subarachnoid CSF accumulation over both optic nerves potentially indicated optic canal stenosis. This assumption was confirmed by 3D CT.</p><p><strong>Results: </strong>The patient underwent decompression of both optic canals with subsequent improvement of visual functions.</p><p><strong>Conclusion: </strong>Vision decrease following Crouzon syndrome may be due to optic canal stenosis. Decompression may be effective, even in long-term course of disease, and improve visual functions.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142018880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Minimally invasive surgical treatment of extramedullary tumors at the level of craniovertebral junction: experience of the Burdenko Neurosurgical Center]. [颅椎骨交界处髓外肿瘤的微创手术治疗:布尔登科神经外科中心的经验]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/neiro20248802139
S V Kaprovoy, N A Konovalov, R A Onoprienko, Yu V Strunina, N D Shmelev

Objective: To describe own experience of treating patients with extramedullary tumors at the level of craniovertebral junction using minimally invasive surgical approaches.

Material and methods: The study included 29 patients who underwent minimally invasive microsurgical resection of extramedullary tumors at the level of craniovertebral junction. We analyzed the main clinical and surgical parameters.

Results: Gross total resection was achieved in most patients with high degree of safety. Two patients required redo surgery due to CSF leakage and soft tissue cyst. Mean length of hospital-stay was 7 days. VAS score of pain syndrome at discharge was 2 points and 0 points after 3 months. No significant differences in neurophysiological monitoring indicators were observed (p=0.76).

Conclusion: Minimally invasive posterior approaches to extramedullary tumors at the level of craniovertebral junction can significantly reduce surgical trauma with equal extent of resection.

目的:描述自己使用微创手术方法治疗颅椎体交界处髓外肿瘤患者的经验:描述自己使用微创手术方法治疗颅椎体交界处髓外肿瘤患者的经验:研究纳入了29例接受微创显微外科手术切除颅椎体交界处髓外肿瘤的患者。我们分析了主要的临床和手术参数:结果:大多数患者都实现了大体全切除,安全性很高。两名患者因脑脊液渗漏和软组织囊肿需要再次手术。平均住院时间为 7 天。出院时疼痛综合征的 VAS 评分为 2 分,3 个月后为 0 分。神经电生理监测指标无明显差异(P=0.76):结论:颅椎交界处髓外肿瘤的后路微创手术可在同等切除范围内显著减少手术创伤。
{"title":"[Minimally invasive surgical treatment of extramedullary tumors at the level of craniovertebral junction: experience of the Burdenko Neurosurgical Center].","authors":"S V Kaprovoy, N A Konovalov, R A Onoprienko, Yu V Strunina, N D Shmelev","doi":"10.17116/neiro20248802139","DOIUrl":"10.17116/neiro20248802139","url":null,"abstract":"<p><strong>Objective: </strong>To describe own experience of treating patients with extramedullary tumors at the level of craniovertebral junction using minimally invasive surgical approaches.</p><p><strong>Material and methods: </strong>The study included 29 patients who underwent minimally invasive microsurgical resection of extramedullary tumors at the level of craniovertebral junction. We analyzed the main clinical and surgical parameters.</p><p><strong>Results: </strong>Gross total resection was achieved in most patients with high degree of safety. Two patients required redo surgery due to CSF leakage and soft tissue cyst. Mean length of hospital-stay was 7 days. VAS score of pain syndrome at discharge was 2 points and 0 points after 3 months. No significant differences in neurophysiological monitoring indicators were observed (<i>p</i>=0.76).</p><p><strong>Conclusion: </strong>Minimally invasive posterior approaches to extramedullary tumors at the level of craniovertebral junction can significantly reduce surgical trauma with equal extent of resection.</p>","PeriodicalId":24032,"journal":{"name":"Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140319443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1